NEW YORK (360Dx) – Avista Capital Partners today announced a definitive agreement to buy anatomic pathology laboratory Miraca Life Sciences.

A new holding company called Symphony Buyer has been formed to become the new owner of MLS, which currently is a wholly owned subsidiary of Japanese holding firm Miraca Holdings. The basic enterprise value of the deal is approximately $175.6 million, Miraca Holdings said, adding it will own 15 percent of Symphony Buyer's shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.